Form4.ai tracks every SEC insider trade in real time. See every EDIT insider filing with a free account — no card.

See every EDIT insider filing

Free account

Editas Medicine, Inc. (EDIT) Insider Trading

Editas Medicine, Inc. (EDIT) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $19K. Most recent filing: Sept. 9, 2026.

Bought vs sold

Open-market value, last 90 days

Sold: $19K (100%)
  • Sold $19K · 100%

What insiders filed

Form 4 filings by type, last 90 days

Sales: 3 (60%) Grants, exercises & other: 2 (40%)
  • Sales 3 · 60%
  • Grants, exercises & other 2 · 40%

At a glance

Insiders trading
5
Largest buy
—
Most recent filing
Sep 9, 2026

Latest EDIT Form 4 filings

Date Insider Trade Value Price since buy
Sep 4, 2026 SEC filing Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Sold $2,153 —
Sep 4, 2026 SEC filing Parison Amy SVP, Chief Financial Officer Sold $1,376 —
Sep 4, 2026 SEC filing O'Neill Gilmore Neil CEO Sold $15,563 —

See every EDIT insider trade

Create a free account to see all 5 EDIT filings from the last 90 days. No card needed.

Create free account

Want EDIT insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.